Zymeworks (ZYME) Revenue (2021 - 2026)
Zymeworks (ZYME) posted Revenue of $2.4 million for Q1 2026, down 4.25% sequentially from $2.5 million in Q4 2025, and down 91.12% YoY from $27.1 million in Q1 2025.
Zymeworks (ZYME) Revenue (2021 - 2026) Analysis & Trends
Zymeworks has reported Revenue for 6 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Revenue fell 91.12% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.3 million (down 12.98% YoY) and the FY2025 annual result came in at $106.0 million, up 38.87% from the prior year.
- Revenue slipped to $2.4 million in Q1 2026 per ZYME's latest filing, from $2.5 million in the prior quarter.
- Over five years, Revenue peaked at $325.0 million in Q4 2022 and troughed at $1.9 million in Q1 2022.
- A 5-year average of $35.0 million and a median of $16.5 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue jumped 3962.5% in 2022, then plunged 94.79% in 2023.
- Over 5 years, Revenue stood at $325.0 million in 2022, then slumped by 94.79% to $16.9 million in 2023, then surged by 83.33% to $31.0 million in 2024, then tumbled by 91.9% to $2.5 million in 2025, then declined by 4.25% to $2.4 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.4 million, $2.5 million, and $27.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Zymeworks | 1.79 Bn | 1.52 Bn | - | 4.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.59 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 27.61 Mn |
| Jun 30, 2025 | 48.73 Mn |
| Mar 31, 2025 | 27.11 Mn |
| Dec 31, 2024 | 31.03 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 19.24 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | 16.93 Mn |
| Sep 30, 2023 | 16.51 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 35.58 Mn |
| Dec 31, 2022 | 325.00 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 8.00 Mn |
| Sep 30, 2021 | 4.40 Mn |